Emma Derrett‐Smith

Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial

Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst et al. · The Lancet Respiratory Medicine · 2020 · 652 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +4

Clinical and pathological significance of interleukin 6 overexpression in systemic sclerosis

Korsa Khan, Shiwen Xu, Svetlana I. Nihtyanova et al. · Annals of the Rheumatic Diseases · 2012 · 218 citations

Medicine, Immunology, Pathology +17

Using Autoantibodies and Cutaneous Subset to Develop Outcome‐Based Disease Classification in Systemic Sclerosis

Svetlana I. Nihtyanova, Jennifer Harvey, Anna Leslie et al. · Arthritis & Rheumatology · 2019 · 214 citations · Full text

Life Sciences, Clinical Sciences, Immunology +16

An Essential Role for Resident Fibroblasts in Experimental Lung Fibrosis Is Defined by Lineage-Specific Deletion of High-Affinity Type II Transforming Growth Factor β Receptor

Rachel K. Hoyles, Emma Derrett‐Smith, Korsa Khan et al. · American Journal of Respiratory and Critical Care Medicine · 2010 · 134 citations

Life Sciences, Molecular Biology, Molecular Genetics +10

The 2024 British Society for Rheumatology guideline for management of systemic sclerosis

Christopher P. Denton, Enrico De Lorenzis, Elen Roblin et al. · Lara D. Veeken · 2024 · 78 citations · Full text

Medicine, Clinical Sciences, Health Assessment +12